Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP pilot study of nebulised versus intravenous tranexamic acid for secondary post-tonsillectomy haemorrhage
ACTRN12621000107820Phase 2Recruiting
- Sponsor
- Perth Children's Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tranexamic acid in postoperative hemorrhage, sponsored by Perth Children's Hospital. Started Oct 2022; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on ACTRN12621000107820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000107820.